Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Payables (2017 - 2026)

Neuronetics has reported Payables over the past 10 years, most recently at $11.4 million for Q1 2026.

  • Quarterly Payables rose 34.79% to $11.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Mar 2026, up 34.79% year-over-year, with the annual reading at $10.7 million for FY2025, 3.05% down from the prior year.
  • Payables was $11.4 million for Q1 2026 at Neuronetics, up from $10.7 million in the prior quarter.
  • Over five years, Payables peaked at $11.6 million in Q3 2025 and troughed at $2.4 million in Q2 2022.
  • The 5-year median for Payables is $4.1 million (2023), against an average of $5.9 million.
  • Year-over-year, Payables plummeted 43.41% in 2022 and then surged 251.23% in 2025.
  • A 5-year view of Payables shows it stood at $2.4 million in 2022, then soared by 95.31% to $4.8 million in 2023, then soared by 133.1% to $11.1 million in 2024, then fell by 3.05% to $10.7 million in 2025, then rose by 6.46% to $11.4 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Payables are $11.4 million (Q1 2026), $10.7 million (Q4 2025), and $11.6 million (Q3 2025).